Corrigendum to "Tumorigenicity of IL-1α- and IL-1β-Deficient Fibrosarcoma Cells" [Neoplasia, Volume 10, Issue 6, June 2008, Pages 549-562]

Affiliations

• ¹ Department of Tumor Progression and Tumor Defense, German Cancer Research Center Heidelberg, Germany.
• ² The Shraga Segal Department of Microbiology and Immunology and the Cancer Center, Ben Gurion University Beer-Sheva, Israel.
• ³ Department of Tumor Progression and Tumor Defense, German Cancer Research Center Heidelberg, Germany; Department of Applied Genetics, University of Karlsruhe. Karlsruhe, Germany.